Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
659 Leser
Artikel bewerten:
(2)

Wanhua Chemical Launches Barcelona R&D Center, Unveiling Signified Focus and Commitment in Europe and Beyond

Finanznachrichten News

BARCELONA, Spain, April 25, 2024 /PRNewswire/ -- The Barcelona R&D Center ("the Center") of Wanhua Chemical (SHA:600309; "the Company"), located at Cornella de Llobregat, has officially opened its doors as a pivotal move by the company to advance its footprint in Europe and beyond with a quicker response to the requirements of downstream customers and bolsters efforts in collaborative scientific research and innovation.

From left to right respectively are: Mr. Bao Hua, the Chairman from Administrative committee of Yantai Economic and technological development area; Mr. Hu Aimin, the Consul General of Chinese consulate in Barcelona; Mr. Roger Torrent Ramio, the Minister of Business and Labor from the government of Catalonia; Mr. Jordi Valls Riera, the Deputy Mayor of Barcelona city consul; Dr. Hua Weiqi, the Executive Vice Presisdent from Wanhua Chemical.

"At Wanhua Chemical, we've always prioritized technological innovation as our core competency. The opening of Barcelona R&D center symbolizes our ongoing commitment to delivering high-quality products and meeting customer needs. We aspire to engage with the industry in a spirit of openness, collaborating to drive innovation and lead the way in sustainable development," said Dr.Hua, Executive Vice President of Wanhua Chemical.

The Center will be poised to quickly meet the needs of downstream customers, offering expert technical consultations on a range of topics, including product performance, application methods, and raw material selection. It will customize solutions to address the specific needs and challenges of its customers, facilitate the development and validation of new products, provide timely technical support for quality concerns, and keep pace with technological advancements in the industry through research and innovation.

The Barcelona R&D Center, an essential measure for the Company to drive sustainability forward, also unveils its ongoing research and development directions, which include green chemistry technology studies, renewable energy utilization, circular economy and waste utilization, and sustainable product development, while actively engaging in international cooperation and standard-setting initiatives. Currently, the Center has established connections with local leading research forces, including the University of Barcelona, the Polytechnic University of Catalonia, the Autonomous University of Catalonia, the Catalonia Institute of Chemical Research, and the Spanish Standardization, with future plans aimed at joint project research acceleration, talent cultivation exchange, and technology transfer facilitation.

Additionally, the Center will assist the company in providing technical support and services to downstream customers in fine chemicals and materials. It will collaborate with leading research institutions and universities for innovative development, fully leveraging external scientific research resources and expertise to drive innovation and enhance competitiveness. Simultaneously, it will serve as the company's stronghold in Europe for attracting talent, especially from Spanish-speaking regions, to support the development of the Latin American market.

Barcelona is Wanhua's second R&D center in Europe. The Gödöllo R&D Center in Hungry focuses on the polyurethane industry, while the Barcelona center will concentrate more on business collaborations within the fine chemicals and materials industries, such as coatings, adhesives and engineering plastics, as well as R&D cooperation with local entities on renewable energy, carbon capture & recycling, biosynthesis, and bio-based materials. Its proximity to Western Europe and the Mediterranean not only enhances support for these regions but also aids development efforts in North Africa and Latin America.

The two centers enhance each other's capabilities in terms of the downstream industries they focus on, the geographical areas they cater to, and the paths they take towards collaborative development, thereby significantly contributing to the growth of Wanhua's international operations.

Barcelona's unique geographical advantage positions it as a gateway to Europe, a regional innovation hub, and an essential center for the global flavor and fragrance chemical industry. It also hosts several leading research institutions, like ICIQ and the Barcelona Institute of Science and Technology, making it an ideal location for Wanhua to showcase its technological advancements and products to Central and Western European clients and partners.

With the strategic move of establishing the Barcelona R&D Center, Wanhua will continue to play an active role, emphasizing its commitment to innovation and sustainable development.

Photo - https://mma.prnewswire.com/media/2397261/From_left_Mr_Bao_Hua_Chairman_Administrative_committee_Yantai_Economic.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/wanhua-chemical-launches-barcelona-rd-center-unveiling-signified-focus-and-commitment-in-europe-and-beyond-302127063.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.